Cargando…
Reduced expression of Nrdp1 predicts a poor prognosis in human hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive form of liver cancer with particularly poor survival rates for patients. Targeted molecular therapies are lacking, and current treatment is generally limited to surgical resection or liver transplantation. Overexpression and aberrant signal...
Autores principales: | Shao, Xian, Lu, Qian, Wang, Gang, Huang, Wei, Yang, Linlin, Chen, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103654/ https://www.ncbi.nlm.nih.gov/pubmed/30154664 http://dx.doi.org/10.2147/OTT.S160638 |
Ejemplares similares
-
Nrdp1S, short variant of Nrdp1, inhibits human glioma progression by increasing Nrdp1‐mediated ErbB3 ubiquitination and degradation
por: Wu, Yuxuan, et al.
Publicado: (2015) -
Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014) -
High expression of TOP2A gene predicted poor prognosis of hepatocellular carcinoma after radical hepatectomy
por: Cai, Hongyu, et al.
Publicado: (2020) -
Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020) -
High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma
por: Li, Songwei, et al.
Publicado: (2021)